

AIM WINNERS & LOSERS: Warpaint tops outlook; Avacta's Covid test works


UK earnings, trading statements calendar - next 7 days


IN BRIEF: Avacta in global Affimer distribution agreement with Abcam


(Sharecast News) - Cancer therapies and diagnostics developer Avacta Group has entered into a global distribution agreement with Abcam, it announced o...


EXECUTIVE CHANGES: Ten Entertainment, Emmerson chairs step down


IN BRIEF: Avacta Group signs diagnostic licensing deal with Biokit


(Sharecast News) - Cancer therapy and diagnostics developer Avacta has entered into a licence agreement with Werfen subsidiary Biokit, it announced on...


IN BRIEF: Avacta's Covid antigen test confirmed to detect variants